Vir Biotechnology, Inc.

VIR ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2022

Total Assets: $2.80B

Liabilities Breakdown FY2022

Total Liabilities: $724.1M